Phreesia, Inc. (PHR)

US — Healthcare Sector

Peers: DH HSTM CPSI CERT NRC NXGN HCAT EVH AGTI CMAX RCM PRVA

Automate Your Wheel Strategy on PHR

With Tiblio's Option Bot, you can configure your own wheel strategy including PHR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

symbol PHR
Rev/Share 7.2037
Book/Share 4.5439
PB 5.6736
Debt/Equity 0.0672
CurrentRatio 1.7828
ROIC -0.222

MktCap 1534020854.0
FreeCF/Share 0.2009
PFCF 131.0457
PE -25.6702
Debt/Assets 0.0458
DivYield 0
ROE -0.2287

Rating C
Score 2
Recommendation Sell
P/E Score 1
DCF Score 4
P/B Score 1
D/E Score 3

Recent Analyst Ratings

Type	Ticker	Analyst Firm	Previous Rating	Current Rating	Previous Price Target	Current Price Target	Date
Upgrade	PHR	RBC Capital Mkts	Sector Perform	Outperform	$24	$32	Jan. 8, 2025

News

Phreesia (PHR) Upgraded to Buy: What Does It Mean for the Stock?

PHR
Published: June 02, 2025 by: Zacks Investment Research
Sentiment: Positive

Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Phreesia (PHR) Upgraded to Buy: What Does It Mean for the Stock?

Phreesia, Inc. (PHR) Q1 2026 Earnings Call Transcript

PHR
Published: May 28, 2025 by: Seeking Alpha
Sentiment: Neutral

Phreesia, Inc. (NYSE:PHR ) Q1 2026 Earnings Conference Call May 28, 2025 8:30 AM ET Company Participants Balaji Gandhi - CFO Chaim Indig - CEO Conference Call Participants Anne Samuel - JPMorgan Jailendra Singh - Truist Securities Jessica Tassan - Piper Sandler Richard Close - Canaccord Genuity John Ransom - Raymond James Daniel Grosslight - Citi William Jellison - D.A. Davidson Ryan MacDonald - Needham & Company Jeff Garro - Stephens Scott Schoenhaus - Keybank Jared Hass - William Blair Aaron Kempson - Citizens JMP Gene Mannheimer - Freedom Capital Markets Joe Vruwink - Baird Operator Good morning, ladies and …

image for news Phreesia, Inc. (PHR) Q1 2026 Earnings Call Transcript

Here's What Key Metrics Tell Us About Phreesia (PHR) Q1 Earnings

PHR
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive

The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended April 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

image for news Here's What Key Metrics Tell Us About Phreesia (PHR) Q1 Earnings

Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates

PHR
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Negative

Phreesia (PHR) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.35 per share a year ago.

image for news Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates

Gear Up for Phreesia (PHR) Q1 Earnings: Wall Street Estimates for Key Metrics

PHR
Published: May 26, 2025 by: Zacks Investment Research
Sentiment: Positive

Beyond analysts' top -and-bottom-line estimates for Phreesia (PHR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended April 2025.

image for news Gear Up for Phreesia (PHR) Q1 Earnings: Wall Street Estimates for Key Metrics

Wall Street Analysts Think Phreesia (PHR) Could Surge 28.02%: Read This Before Placing a Bet

PHR
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Positive

The consensus price target hints at a 28% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Wall Street Analysts Think Phreesia (PHR) Could Surge 28.02%: Read This Before Placing a Bet

Phreesia's Sally Thayer Selected as a Top Woman Leader in Software

PHR
Published: February 11, 2025 by: Business Wire
Sentiment: Neutral

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that Sally Thayer, VP of Product Management, is a winner for The Software Report's 2024 list of Top 50 Women Leaders in Software.

image for news Phreesia's Sally Thayer Selected as a Top Woman Leader in Software

About Phreesia, Inc. (PHR)

IPO Date 2019-07-18
Website https://www.phreesia.com
Industry Medical - Healthcare Information Services
CEO Mr. Chaim Indig
Employees 2082

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.